Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Valneva SE

Valneva SE (VALN) Stock Overview

Explore Valneva SE’s financial performance, market position, analyst ratings, and future outlook.

VALN●NASDAQ
HealthcareBiotechnology
$6.75
$0.21(3.02%)
U.S. Market opens in 12h 26m

Valneva SE (VALN)

Meyka AI Score

Z

Key Financials

Market Cap640.1M
P/E Ratio-3.20
EPS (TTM)$-2.11
ROE-1.53%
Fundamental Analysis

AI Price Forecasts

1 Month$2.54
3 Months$3.56
1 Year Target$10.45

VALN Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Valneva SE (NASDAQ: VALN) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Valneva SE's NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of VALN on the NASDAQ shows an RSI of 69.46, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $10.45 for the NASDAQ listing.

Key metrics behind Valneva SE's NASDAQ-traded stock include a P/E ratio of -3.20 and a market capitalization of 640.1M. Combined with our AI analysis, these give both institutional and retail investors a clear view of VALN on the NASDAQ.

Price Performance (NASDAQ: VALN)

1-Day Change
-3.02%
5-Day Change
-4.12%
1-Month Change
41.21%
3-Month Change
13.83%
6-Month Change
-43.70%
Year-to-Date (YTD) Change
-23.47%
1-Year Change
-28.42%
3-Year Change
-51.79%
5-Year Change
-81.25%
All-Time (Max) Change
-74.44%

Contact Information

https://valneva.com
33 2 28 07 37 10
6 rue Alain Bombard, Saint-Herblain, GE, 44800

Company Facts

6,740 Employees
IPO DateMay 5, 2021
CountryFR
Actively Trading

Frequently Asked Questions